Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
ZymoGenetics, Inc. (ZGEN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ZGEN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Making and Breaking Biotech Deals
Dec 14
•
The Burrill Report
•
Comment!
Biotech's Latest Failed Trials, Missed Targets
Dec 14
•
The Burrill Report
•
1 Comment
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Tuesday's Options Recap
Sep 1
•
Frederic Ruffy
•
1 Comment
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
5 Comments
Failure to Launch for Last Year's Big Pharma and Biotech Hopes
Feb 13
•
EP Vantage
•
Comment!
Five Biotech Stocks to Weather a Down Market
Apr 22, 2008
•
Zacks.com
•
1 Comment
Biotech Stocks: Sector Outlook and Top Picks
Apr 8, 2008
•
Zacks.com
•
1 Comment
Tuesday's Options Report: UAUA, Adobe, ZGEN, NLS, KWK, WPZ, Best Buy, GS
Dec 18, 2007
•
Andrew Wilkinson
•
Comment!
Top 10 Emerging Biotech Stocks
Oct 15, 2007
•
Mike Havrilla
•
1 Comment
Biotech Day in Review: Avalon Signs $200 Million Deal with Merck
Mar 8, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Stock Review: GPC Biotech Completes New Drug Approval
Feb 20, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status For Onconase
Jan 31, 2007
•
Centient Biotech Investor
•
Comment!